AIM
MNTA

Advantage Investment Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Advantage Investment Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-293
Closed -$4K – 912
2014
Q4 		$4K Buy
+293
New +$3.35K ﹤0.01% 648

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Advantage Investment Management's MNTA Position: Q1 2015 in Review

Advantage Investment Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2015, closing a stake of 293 shares — an estimated $4K sold.

Advantage Investment Management first reported a position in MNTA in Q4 2014 and held it in 1 quarter. The position peaked at $4K in Q4 2014. 143 funds tracked by Wall St. Rank hold MNTA as of Q1 2015.

  • Advantage Investment Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
  • Advantage Investment Management sold 293 Momenta Pharmaceuticals, Inc. shares in Q1 2015, an estimated $4K.
  • Advantage Investment Management first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2014 and held it in 1 quarter.
  • Advantage Investment Management's Momenta Pharmaceuticals, Inc. position peaked at $4K in Q4 2014.
  • 143 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2015.

Based on Advantage Investment Management's 13F filing for Q1 2015, filed 27 Mar 2017.